Abstract
Common features in the interaction of tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives with the human immunodeficiency virus type 1 reverse transcriptase.
Z Debyser, R Pauwels, M Baba, J Desmyter and E De Clercq
Molecular Pharmacology May 1992, 41 (5) 963-968;